Phase I – Other

1,064 trials 249 recruiting

Filter these 1,064 trials by condition, country, sponsor and more.

Open in Search →

An Open label, Single Arm, Single dose Study in Pediatric Participants aged ≥2 to <12 years with a Suspected or Confirmed Bacterial Infecti… Pending

2025-522916-17-00 Urinary Tract Infections
The NIMBUS study: A study on inhalation therapy with liposomal amphotericin B and its distribution in the lungs in chronic pulmonary fungal … Pending

2025-521770-34-00 Chronic pulmonary aspergillosis
A study of Mirdametinib in Infants and Toddlers under 24months of age with Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas… Pending

2025-522000-24-00 Neurofibromatosis Type 1 (NF1) Associated Plexiform Neu
Phase I study of CDK8 inhibitor RVU120 in combination with everolimus in children with recurrent or progressive Group 3 or 4 medulloblastoma… Pending

2025-524031-39-00 Medulloblastoma (recurrent or progressive)
A study to learn more about the amount of bimekizumab in the breast milk of women with chronic inflammatory conditions who are breastfeeding Pending

2024-518689-29-00 Hidradenitis suppurativa
SIE-1 Recruiting

2025-523269-31-00 Hormone receptor-positive early breast cancer in post-m 2026-06-02
Phase 1b Study of Tarlatamab + ZL-1310 +/- Anti-PD-L1 in Small Cell Lung Cancer Recruiting

2025-522888-15-00 Small Cell Lung Cancer 2026-05-27
Study Investigating Tucatinib and Osimertinib Pharmacokinetics in Primary and Metastatic Brain Tumors: the STICK trial Recruiting

2025-522128-28-00 Breast cancer 2026-05-26
150 mg CIT-013 phase 1 trial Recruiting

2026-526153-34-00 Immune mediated inflammatory diseases 2026-05-26
A study to test how well different doses of BI 3820768 are tolerated by people with advanced cancer (solid tumours) Recruiting

2025-522913-45-00 Advanced relapsed or refractory ovarian cancer 2026-05-21
Phase 1 trial of valemetostat and darolutamide in mCRPC Recruiting

2025-522512-16-00 Metastatic Castration Resistant Prostate Cancer (mCRPC) 2026-04-23
A study to determine the safety and effect of antibodies against hepatitis D (the SAMBA-D study) Recruiting

2025-522125-36-00 Chronic hepatitis D infection 2026-04-22
A Phase I Dose Escalation and Dose Expansion Study to Investigate the Pharmacokinetics and Safety of Subcutaneous Durvalumab. Recruiting

2025-521639-34-00 • Non-small cell lung cancer (Stage III, unresectable) 2026-04-20
A study to learn if bimekizumab given in different ways is safe and moves similarly throughout the body over time in adults Recruiting

2025-522782-30-00 CCI 2026-04-07
A study to learn about how safe BAY 3389934 is, its suitable dose, and how it affects the participants with sepsis and coagulopathy Recruiting

2024-515635-30-00 Coagulopathy 2026-03-24
A Long-Term Follow-up Study for Subjects Previously Treated with A Century Therapeutics Cellular Therapy Product Recruiting

2024-520222-11-00 Hematological or solid tumor malignancies or autoimmune 2026-03-03
A Phase 1, Open-Label, Multicenter Study of INCB160058 in Participants With Myeloproliferative Neoplasms. Recruiting

2024-520353-21-00 Myeloproliferative Neoplasms 2026-02-24
A study to investigate safety, tolerability, pharmacokinetics, and pharmacodynamics of surovatamig in adult participants with rheumatoid art… Recruiting

2025-522273-10-00 Systemic Lupus Erythematosus 2026-02-24
A PK study to compare JPB898 (proposed nivolumab biosimilar) and US-licensed Opdivo® in participants with resected stage IIB, IIC, or III me… Recruiting

2025-521919-39-00 Resected stage IIB, IIC, or III melanoma requiring adju 2026-02-10
NON-IV: Neo-adjuvant peritumOral immuNotherapy In Vulvar cancer Recruiting

2025-520712-34-00 Vulvar Cancer 2026-02-04
A study of gilteritinib in adults with advanced ALK-positive non-small cell lung cancer (NSCLC) Recruiting

2025-522398-12-00 Locally advanced or metastatic NSCLC 2026-01-30
Personalized Treatment for Endometriosis: A Study on the Safety and Kinetics of Dienogest in Women with Different Gene Variants Recruiting

2025-521026-15-00 Healthy volunteers 2025-12-11
A Study of an IDH1m Inhibitor in Participants with IDH1-Mutated Malignancies and Hepatic or Renal Impairment Recruiting

2024-517923-38-00 Newly diagnosed and/or previously treated IDH1-mutated 2025-12-10
A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions of ABBV-319 in Adult Partic… Recruiting

2024-519157-10-00 Systemic Lupus Erythematosus 2025-11-24